Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years - how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Authors: Hudson P.B.; Boake R.; Trachtenberg J.; Romas N.A.; Rosenblatt S.; Narayan P.; Geller J.; Lieber M.M.; Elhilali M.; Norman R.; Patterson L.; Perreault J.-P.; Malek G.H.; Bruskewitz R.C.; Roy J.B.; Ko A.; Jacobsen C.A.; Stoner E.

Source: Urology, Volume 53, Number 4, April 1999 , pp. 690-695(6)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0090-4295(98)00666-9

Affiliations: 1: pMerck Research Laboratories, Rahway, New Jersey, USA

Publication date: 1999-04-01

• In this: publication
• By this: publisher
• In this Subject: Urology
• By this author: Hudson P.B. ;  Boake R. ;  Trachtenberg J. ;  Romas N.A. ;  Rosenblatt S. ;  Narayan P. ;  Geller J. ;  Lieber M.M. ;  Elhilali M. ;  Norman R. ;  Patterson L. ;  Perreault J.-P. ;  Malek G.H. ;  Bruskewitz R.C. ;  Roy J.B. ;  Ko A. ;  Jacobsen C.A. ;  Stoner E.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers